2Dansh J,Wheeler JG,Hirschfield GM. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J].{H}New England Journal of Medicine,2013.1387-1397.
3Novo G,Assennato I,Caruso M. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome[J].{H}Minerva Cardioangiologica,2009.97-111.
4Ndrepepa G,Braun S,Iijima R. Total leucocyte count,but not C-reactive protein,predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention[J].{H}Clin Sci(Lond),2009.651-658.
5Senturk T,Sarandol E,Gullulu S. Serum arylesterase activity is negatively correlated with inflammatory markers in patients with acute coronary syndromes[J].{H}SAUDI MEDICAL Journal,2009.334-339.
6Chu JW,Jones GT,Tarr GP. Plasma active matrix metalloproteinase 9 and indices of diastolic function in patients with preserved systolic function[J].{H}International Journal of Cardiology,2013.1242-1246.
7Alp E,Menevse S,Tulmac M. The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction[J].Genet Test Mol Biomarkers,2012.193-202.
8Kaski JC,Consuegra-Sanchez L,Fernandez-Berges DJ. Elevated serum neopterin levels and adverse cardiac events at 6 months follow up in Mediterranean patients with non-ST-seg-ment elevation acute coronary syndrome[J].{H}ATHEROSCLEROSIS,2008.176-183.
9Ray KK,Morrow DA,Sabatine MS. Long-term prognostic value of neopterin:a novel marker of monocyte activation in patients with acute coronary syndrome[J].{H}CIRCULATION,2007.3071-3078.
10Narain VS,Gupta N,Sethi R. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome[J].{H}Indian Heart Journal,2008.536-542.
